Literature DB >> 17885348

Are the contents of treatment outcomes in fibromyalgia trials represented in the International Classification Of Functioning, Disability, and Health?

Martin Offenbächer1, Alarcos Cieza, Thomas Brockow, Edda Amann, Barbara Kollerits, Gerold Stucki.   

Abstract

OBJECTIVES: To identify the concepts contained in treatment outcomes of randomized controlled trials (RCTs) for interventions in patients with fibromyalgia (FM) using the International Classification of Functioning, Disability, and Health (ICF) as external reference.
METHODS: RCTs between 1992 and 2001 were located in MEDLINE and selected according to predefined eligibility criteria. The outcome measures were extracted and the concepts within the outcome measures were identified and linked to the ICF using a content-analytical approach.
RESULTS: Forty-two trials on FM were included. Twenty-seven different questionnaires were extracted. Of all, 79.2% (N=236) of the clinical and physiologic outcomes could be linked to 31 different ICF categories and 84.7% (N=964) of the concepts contained in the health-status questionnaire to 113 ICF categories.
CONCLUSIONS: The ICF provides a useful external reference to identify the concepts contained in outcome measures used in RCTs in FM.

Entities:  

Mesh:

Year:  2007        PMID: 17885348     DOI: 10.1097/AJP.0b013e318148b93d

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  14 in total

Review 1.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

2.  The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Banafsheh Ghavidel Parsa; Alireza Amir Maafi; Afrooz Haghdoost; Yasaman Arabi; Monire Khojamli; Gelayol Chatrnour; Ali Bidari
Journal:  Rheumatol Int       Date:  2014-01-01       Impact factor: 2.631

3.  The validity and reliability of the Moroccan version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Najlaa Srifi; Rachid Bahiri; Samira Rostom; Imad Bendeddouche; Noufissa Lazrek; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2013-01       Impact factor: 2.631

Review 4.  Societal and patient burden of fibromyalgia syndrome.

Authors:  Lieven Annemans; Katell Le Lay; Charles Taïeb
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Validation of the Arabic version of the revised Fibromyalgia Impact Questionnaire (FIQR_A) on Jordanian females with fibromyalgia.

Authors:  Sana Abu-Dahab; Salah M AbuRuz; Khader Mustafa; Yusef Sarhan
Journal:  Clin Rheumatol       Date:  2013-07-31       Impact factor: 2.980

6.  The validity and reliability of the Turkish version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Levent Ediz; Ozcan Hiz; Murat Toprak; Ibrahım Tekeoglu; Songul Ercan
Journal:  Clin Rheumatol       Date:  2010-08-12       Impact factor: 2.980

7.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Authors:  Robert M Bennett; Ronald Friend; Kim D Jones; Rachel Ward; Bobby K Han; Rebecca L Ross
Journal:  Arthritis Res Ther       Date:  2009-08-10       Impact factor: 5.156

8.  Fibromyalgia syndrome module at OMERACT 9: domain construct.

Authors:  Philip Mease; Lesley M Arnold; Ernest H Choy; Daniel J Clauw; Leslie J Crofford; Jennifer M Glass; Susan A Martin; Jessica Morea; Lee Simon; C Vibeke Strand; David A Williams
Journal:  J Rheumatol       Date:  2009-10       Impact factor: 4.666

9.  Active and sham transcranial direct current stimulation (tDCS) improved quality of life in female patients with fibromyalgia.

Authors:  N Samartin-Veiga; A J González-Villar; M Pidal-Miranda; A Vázquez-Millán; M T Carrillo-de-la-Peña
Journal:  Qual Life Res       Date:  2022-03-01       Impact factor: 3.440

10.  Validation of a Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR).

Authors:  Monika Salgueiro; Juan Miguel García-Leiva; Javier Ballesteros; Javier Hidalgo; Rocío Molina; Elena P Calandre
Journal:  Health Qual Life Outcomes       Date:  2013-08-01       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.